TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Brandon D. Lawrence(University of Utah), Jonathan A. Fletcher(Harvard University), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Paola Dal Cin(Brigham and Women's Hospital), Eunhee S. Yi(Hubei University), Antonio R. Pérez‐Atayde(Boston Children's Hospital), Sheng Xiao(Brigham and Women's Hospital), Jack L. Pinkus(Brigham and Women's Hospital), Brian P. Rubin(Cleveland Clinic), Geraldine S. Pinkus(Brigham and Women's Hospital), M K Hibbard(Brigham and Women's Hospital)
Cited by 716
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
|Nature|2000|1.7k